The novel microtubule targeting agent BAL101553 in combination with radiotherapy in treatment-refractory tumor models. (Record no. 27455274)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01560 a2200409 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517170223.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201801s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1879-0887 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/j.radonc.2017.07.024 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Sharma, Ashish |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20180108 |
| 245 00 - TITLE STATEMENT | |
| Title | The novel microtubule targeting agent BAL101553 in combination with radiotherapy in treatment-refractory tumor models. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology |
| Date of publication, distribution, etc. | 09 2017 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 433-438 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Benzimidazoles |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Line, Tumor |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Chemoradiotherapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Microtubules |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasms, Experimental |
| General subdivision | pathology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Oxadiazoles |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Broggini-Tenzer, Angela |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vuong, Van |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Messikommer, Alessandra |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nytko, Katarzyna J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Guckenberger, Matthias |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bachmann, Felix |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lane, Heidi A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Pruschy, Martin |
| 773 0# - HOST ITEM ENTRY | |
| Title | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology |
| Related parts | vol. 124 |
| -- | no. 3 |
| -- | p. 433-438 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.radonc.2017.07.024">https://doi.org/10.1016/j.radonc.2017.07.024</a> |
| Public note | Available from publisher's website |
No items available.